These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34889358)

  • 1. Gene therapy for sickle cell disease: where we are now?
    Kanter J; Falcon C
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):174-180. PubMed ID: 34889358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for sickle cell disease: moving from the bench to the bedside.
    Abraham AA; Tisdale JF
    Blood; 2021 Sep; 138(11):932-941. PubMed ID: 34232993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
    Bauer DE; Brendel C; Fitzhugh CD
    Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing.
    Locatelli F; Corbacioglu S; Hobbs W; Frangoul H; Walters MC
    Am J Hematol; 2024 Mar; 99(3):430-438. PubMed ID: 38010293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reach.
    Eckrich MJ; Frangoul H
    Semin Hematol; 2023 Jan; 60(1):3-9. PubMed ID: 37080708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapies on the horizon for sickle cell disease: a clinician's perspective.
    Butt H; Tisdale JF
    Expert Rev Hematol; 2024 Sep; 17(9):555-566. PubMed ID: 39076056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational curative gene therapy approaches to sickle cell disease.
    Williams DA; Esrick E
    Blood Adv; 2021 Dec; 5(23):5452. PubMed ID: 34905048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges - review article.
    Youssry I; Ayad N
    Ann Hematol; 2024 Aug; 103(8):2613-2619. PubMed ID: 37867187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 gene editing for curing sickle cell disease.
    Park SH; Bao G
    Transfus Apher Sci; 2021 Feb; 60(1):103060. PubMed ID: 33455878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Treatment with curative intent": the emergence of genetic therapies for sickle cell anemia.
    Benz EJ; Silberstein LE; Panepinto J
    Blood; 2024 Mar; 143(11):967-970. PubMed ID: 38289232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for sickle cell disease.
    Leonard A; Tisdale JF
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):542-547. PubMed ID: 38066927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promise of gene therapy to treat sickle cell disease.
    Romero Z; DeWitt M; Walters MC
    Expert Opin Biol Ther; 2018 Nov; 18(11):1123-1136. PubMed ID: 30324810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced.
    Leonard A; Tisdale JF
    Expert Rev Hematol; 2018 Jul; 11(7):547-565. PubMed ID: 29883237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy as the New Frontier for Sickle Cell Disease.
    Garg H; Tatiossian KJ; Peppel K; Kato GJ; Herzog E
    Curr Med Chem; 2022; 29(3):453-466. PubMed ID: 34047257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo HSC prime editing rescues sickle cell disease in a mouse model.
    Li C; Georgakopoulou A; Newby GA; Chen PJ; Everette KA; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A
    Blood; 2023 Apr; 141(17):2085-2099. PubMed ID: 36800642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state of gene therapy in sickle cell disease.
    Tang MS; Shan H
    Vox Sang; 2024 Jun; 119(6):521-528. PubMed ID: 38487952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
    Hollister BM; Gatter MC; Abdallah KE; Armsby AJ; Buscetta AJ; Byeon YJJ; Cooper KE; Desine S; Persaud A; Ormond KE; Bonham VL
    CRISPR J; 2019 Dec; 2(6):441-449. PubMed ID: 31742431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Genetic Therapy for Sickle Cell Disease.
    Orkin SH; Bauer DE
    Annu Rev Med; 2019 Jan; 70():257-271. PubMed ID: 30355263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse Approaches to Gene Therapy of Sickle Cell Disease.
    White SL; Hart K; Kohn DB
    Annu Rev Med; 2023 Jan; 74():473-487. PubMed ID: 36067800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.